Information about Fintepla for patients and their caregivers
This website has been designed to give information about Fintepla (fenfluramine) to patients who have been prescribed Fintepla, and also to caregivers of patients who have been prescribed Fintepla.
This website is intended for patients in Europe who have been prescribed Fintepla and their caregivers
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you or the person you care for may experience. See the What to look out for section for how to report side effects.
Fintepla is a medicine which is prescribed to treat the seizures that patients with Dravet syndrome can experience. Fintepla is used with other drugs to treat seizures in Dravet syndrome patients aged 2 years of age and older.
Dravet syndrome is a rare form of epilepsy which usually starts when a child is less than 1 year old. Patients who suffer from it often have very frequent and severe seizures. You can learn more about Dravet syndrome here.